The Welch Foundation is one of the nation’s largest private funding sources for fundamental chemical research at universities, colleges and other educational institutions in Texas.
2026 WelchX Collaboration Retreat - Call for Applications
The 2026 WelchX retreat will take place in Houston, TX from June 8-11, 2026. The retreat’s activities are designed to spur creative, innovative, collaborative ideas that address the most challenging and unexplored issues in bioorganic, medicinal, analytical, and macromolecular chemistry that relate to biological processes; the chemistry of life in its broadest interpretation. Applications are due February 28, 2026.
The Welch Foundation has awarded the 2026 Norman Hackerman Award in Chemical Research to Dr. Sheel Dodani, associate professor in the Department of Chemistry and Biochemistry at The University of Texas at Dallas, for her pioneering contributions to the development of engineered proteins as anion sensors in biology. Congratulations to Dr. Dodani!
The purpose of The Welch Award in Chemistry is to foster and encourage basic chemical research and to recognize, in a substantial manner, the value of chemical research contributions for the benefit of humankind. Any person can be considered for the award who has made important chemical research contributions which have a significant, positive influence on humankind.
A research grant provides $117,000 per year in funding to support research in chemistry by a full-time regular faculty member with tenure or on tenure-track who serves as principal investigator. Applications are restricted to universities, colleges, or other educational institutions located within the state of Texas and also listed as an educational institution by the Texas Higher Education Coordinating Board.
2025 Welch Award in Chemistry Recipients Stuart L. Schreiber and Peter G. Schultz
The Welch Foundation has awarded the 2025 Robert A. Welch Award in Chemistry to Stuart L. Schreiber and Peter G. Schultz.
Dr. Schreiber, of Harvard University and Arena BioWorks, is honored for his profound discoveries using chemical probes to understand the chemical machinery of the cell and for developing therapies based on this knowledge. Dr. Schultz, from Scripps Research, is recognized for his pioneering contributions to creating new letters in the alphabet of life, and the leveraging of chemical diversity to discover novel therapeutics and materials.